Procainamide Hci Injection, Solution
Product Images NDC 51662-1334

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Procainamide Hci (NDC 51662-1334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure Desc)

Chemical structure of Procainamide HCl showing the molecular composition with a benzene ring, amide group, diethylamino group, and hydrochloride component.*

FDA Label Image

D1 (Dosage And Administration)

A data table titled "DILUTIONS AND RATES FOR INTRAVENOUS INFUSIONS" for Procainamide Hydrochloride Injection, USP, presenting final concentrations, infusion volumes, procainamide hydrochloride amounts to be added, and infusion rates for initial loading and maintenance infusions. It includes notes on infusion volume preparation with 5% Dextrose Injection and warnings about monitoring infusion flow rates to avoid high plasma levels and hypotension.*

FDA Label Image

How Supplied (How Supplied)

A data table listing two NDC numbers for fliptopp vials with concentrations and sizes: 100 mg/mL in a 10 mL vial and 500 mg/mL in a 2 mL vial.*

FDA Label Image

Logo (Logo)

FDA Label Image

Vial Label (Vial Label)

Label for PROCAINAMIDE HCl Injection, USP 100 mg/mL, 10 mL multiple-dose vial. The label states 1 gram per 10 mL total, includes preservative methylparaben and sodium metabisulfite, with a warning about metabisulfites. Manufactured by Hospira, Inc.*

FDA Label Image

Box Label (Box Label)

Label for PROCAINAMIDE HYDROCHLORIDE Injection, USP, 100 mg/mL (1 gram/10 mL total) in a 10 mL multiple-dose vial. The label includes warnings about preservatives like methylparaben and sodium metabisulfite, instructions for aseptic technique, storage conditions, and notes that the solution is sterile and nonpyrogenic for intramuscular or intravenous use. Manufactured by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Rfid Label (51662 1334 1 Rfid Label)

A label featuring barcoded numeric data and text for distribution information. It includes details such as 'SEE MANUFACTURE'S INSERT' and notes distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label contains a data matrix barcode on the right side and several lines of encoded numeric and alphanumeric codes on the left.*

FDA Label Image

Pouch Labeling (51662 1334 2 Serialized Pouch Label)

Label for PROCAINAMIDE HCl Injection, USP 100 mg/mL, 10 mL vial. The label shows the NDC 51662-1334-2 and details for intravenous or intramuscular use. It includes storage instructions, warnings about preservatives and sulfites, manufacturer information (HF Acquisition Co., LLC, Mukilteo, WA), and a QR code.*

FDA Label Image

Box Labeling (51662 1334 3 Serialized Case Labeling)

A label on white packaging showing a GS1 DataMatrix barcode and GS1 Application Identifiers (01, 17, 21, 10) with corresponding numeric values. The label notes the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275, and includes the text 'RX ONLY'. No product name, dosage form, or strength is visible.*

FDA Label Image

Box Labeling (51662 1334 3 Serialized Case Label)

Label for PROCAINAMIDE HCl Injection, USP 1 gram/10 mL (100 mg/mL) solution in a 10 mL vial, box of 25. It includes NDC 51662-1334-3, lot number 123456, and expiration date 2030-01-01. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Intended for intravenous or intramuscular use with warnings about preservatives and storage conditions.*

FDA Label Image

Pouch Updated (51662 1334 2 Pouch Updated)

Label for PROCAINAMIDE HCI Injection, USP, 100 mg/mL in a 10 mL vial (1 gram/10 mL total). The label includes NDC 51662-1334-2, lot number, expiration date, manufacturer HF Acquisition Co LLC, and directions for intraveneous or intramuscular use after dilution.*

FDA Label Image

Case Update (51662 1334 3 Case Updated)

Label for PROCAINAMIDE HCI Injection, USP 1 gram per 10 mL (100 mg/mL) 10 mL vial by HF Acquisition Co LLC DBA HealthFirst. The label includes NDC 51662-1334-3, lot and expiration details, warnings for intravenous or intramuscular use, and storage instructions at controlled room temperature.*

FDA Label Image

Rfid Update (51662 1334 3 Serialized Rfid Label Updated)

A small white label featuring two barcodes and several numeric codes including (01) 00351662133439 and (17) 300101. The label instructs to see the manufacturer HealthFirst Acquisition Co LLC in Mukilteo, WA for the package insert. The label also notes 'RX ONLY' indicating prescription use.*

FDA Label Image

Serialized Label (51662 1334 3 Rfid Case)

Partial label on a white packaging for PROCAINAMIDE HCI injection, a human prescription drug by HF Acquisition Co LLC, DBA HealthFirst. The label shows coding with numeric identifiers, the text "SEE MANUFACTURE'S INSERT" and distributor information in Mukilteo, WA, along with a Data Matrix barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.